Embryonic stem (ES) cells are pluripotent cells directly derived from early
stage embryos that retain the ability to differentiate into all cell types
. This unique feature is the basis of various applications of ES cell techn
ology such as in vitro models of mammalian development, germline transgenes
is to make knockout mice, and a generic source for cell therapy in regenera
tive medicine. To achieve success in these applications, the pluripotency o
f ES cells has to be kept stable during long-term culture in vitro, leading
to the necessity of determining the molecular basis for maintaining ES sel
f-renewal. This paper summarizes the recent progress in this area, focusing
mainly on the LIF signaling pathway and the transcription factor Oct-3/4.
Although it is still unclear how these components works together, a model i
s presented here that provides a plan to solve this problem.